FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 30 filers reported holding FORTE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,592 | -36.4% | 182,164 | -0.1% | 0.00% | – |
| Q2 2023 | $189,619 | -1.9% | 182,326 | -4.7% | 0.00% | – |
| Q1 2023 | $193,321 | -8.8% | 191,407 | -9.7% | 0.00% | – |
| Q4 2022 | $211,876 | -6.2% | 211,876 | -0.1% | 0.00% | – |
| Q3 2022 | $226,000 | -18.7% | 212,061 | -0.9% | 0.00% | – |
| Q2 2022 | $278,000 | -76.4% | 214,043 | -73.4% | 0.00% | – |
| Q1 2022 | $1,176,000 | -32.7% | 806,015 | -1.4% | 0.00% | – |
| Q4 2021 | $1,748,000 | -23.5% | 817,063 | +5.9% | 0.00% | – |
| Q3 2021 | $2,284,000 | -91.2% | 771,726 | -0.4% | 0.00% | -100.0% |
| Q2 2021 | $26,059,000 | +190.6% | 775,119 | +196.2% | 0.00% | – |
| Q1 2021 | $8,968,000 | +62.8% | 261,669 | +73.0% | 0.00% | – |
| Q4 2020 | $5,507,000 | +7.9% | 151,253 | +43.8% | 0.00% | – |
| Q3 2020 | $5,102,000 | +607.6% | 105,164 | +112.7% | 0.00% | – |
| Q2 2020 | $721,000 | – | 49,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 84,989 | $3,094,000 | 1.41% |
| BVF INC/IL | 718,788 | $26,171,000 | 1.03% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $106,926,000 | 0.83% |
| MYDA Advisors LLC | 28,000 | $1,019,000 | 0.30% |
| Maven Securities LTD | 83,374 | $3,036,000 | 0.30% |
| Parkman Healthcare Partners LLC | 31,098 | $1,132,000 | 0.29% |
| Woodline Partners LP | 192,266 | $7,000,000 | 0.19% |
| Sepio Capital, LP | 58,591 | $2,133,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 325,000 | $11,833,000 | 0.17% |
| Perceptive Advisors | 350,000 | $12,744,000 | 0.14% |